Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/23/19 → 06/1/24 |
Funding
- ICON Clinical Research: $65,852.70
Trevi Therapeutics: A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, 2-Arm, Efficacy, and Safety Study in Prurigo Nodularis with Nalbuphine ER tablets for Pruritus Relief through Itch Scratch Modulation
- Kaufmann, Tara (PI)
- Salvemini, Joann (CoPI)
- Silverstein, David (CoPI)
Project: Research